TABLE 3.
Univariate and multivariate logistic regression analyses for severe TR 6 months after TMVR
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| OR (95% CI) | p‐value | OR (95% CI) | p‐value | |
| Age | ||||
| < 70 years | 1.0 | |||
| 70–79 years | 4.07 (1.34–12.37) | .01 | 11.99 (1.94–74.01) | .007 |
| ≥ 80 years | 4.67 (1.60–13.58) | .005 | 13.88 (2.26–85.08) | .004 |
| Gender | ||||
| Male | 1.0 | |||
| Female | 1.38 (0.70–2.73) | .35 | ||
| AF | ||||
| No | 1.0 | |||
| Yes | 3.19 (1.49–6.84) | .003 | 3.67 (1.31–10.29) | .01 |
| STS score (per % increase) | 1.08 (0.98–1.19) | .12 | ||
| BMI | ||||
| < 26 kg/m2 | 1.0 | |||
| ≥ 26 kg/m2 | 0.51 (0.25–1.01) | .05 | ||
| Hypertension | ||||
| No | 1.0 | |||
| Yes | 1.83 (0.88–3.78) | .10 | ||
| Previous PCI | ||||
| No | 1.0 | |||
| Yes | 0.50 (0.21–1.21) | .13 | ||
| 6‐MWT distance (per meter increase) | 1.00 (0.99–1.00) | .05 | ||
| TAPSE | ||||
| > 17 mm | 1.0 | |||
| ≤ 17 mm | 1.97 (0.98–3.97) | .06 | 3.02 (1.19–7.68) | .02 |
| TAD | ||||
| ≤ 40 mm | 1.0 | |||
| > 40 mm | 2.61 (1.21–5.64) | .02 | ||
| MR reduction | ||||
| No reduction | 1.0 | |||
| 1 grade | 0.24 (0.07–0.83) | .02 | 0.14 (0.03–0.74) | .02 |
| > 1 grade | 0.21 (0.07–0.65) | .007 | 0.15 (0.03–0.69) | .02 |
Abbreviations: 6‐MWT, six minute walk test; AF, atrial fibrillation; BMI, body mass index; CI, confidence interval; MR, mitral regurgitation; OR, odds ratio; PCI, percutaneous coronary intervention; STS, Society of Thoracic Surgeons; TAD, tricuspid annulus dimension; TAPSE, tricuspid annular plane systolic excursion; TMVR, transcatheter mitral valve repair.